podophyllotoxin has been researched along with Nausea in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 29 (93.55) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (6.45) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrick, B; Clemmons, AB; DeRemer, D; Gandhi, A; Orr, J; Sportes, C | 1 |
Clark, SM; Clemmons, AB; DeRemer, DL; Garren, J; Kota, VK; Schaack, L | 1 |
Bitran, JD; DeMeester, TR; Golomb, HM; Hoffman, PC; Newman, SB; Raghavan, V | 1 |
Canellos, GP; Garnick, MB; Lederman, GS; Richie, JP | 1 |
Davis, SL; Goodman, GE; Manning, MM; McMahon, LJ; Miller, TP | 1 |
Choo, YC; Ma, HK; Wong, LC | 1 |
Araya, Y; Dosaka, H; Isobe, H; Ito, M; Kawakami, Y; Miyamoto, H; Onodera, S; Shimizu, T; Takaoka, K | 1 |
Greco, FA; Hainsworth, JD; Johnson, DH; Wolff, SN | 1 |
Hattori, K; Ito, K; Kobayashi, S; Nakamura, S; Nakanishi, J; Ohtake, S; Yoshida, T | 1 |
Colombo, N; D'Incalci, M; Landoni, F; Mangioni, C; Sessa, C | 1 |
Aisner, J; Van Echo, DA; Wiernik, PH | 1 |
Jankowski, RP; Vahrson, H | 1 |
Decker, DG; Edmonson, JH; Jorgensen, EO; Malkasian, GD; Webb, MJ | 1 |
Gauthier, H; Huguenin, P; Lheritier, J; Mathe, G; Morin, P; Parrot, R; Poisson, M; Pouillart, P; Thy, TH | 1 |
Anderson, PN; Baker, LH; Comis, RL; Daniels, JR; Einhorn, LH; Harvey, HA; Issell, BF; Lanzotti, VA; Lawson, RD; Wampler, GL | 1 |
Fukuoka, M; Hirano, M; Honma, T; Hoshino, A; Meguro, S; Nakamura, T; Ogawa, M; Shirakawa, S; Toki, H; Yoshida, S | 1 |
Bosl, GJ; Golbey, RB; Herr, H; MacDonald, G; Morse, M; Sogani, P; Vogelzang, N; Whitmore, W; Yagoda, A | 1 |
Chikata, E; Hara, K; Ito, F; Kado, M; Kanda, T; Matsui, Y; Nakayama, M; Ohshima, S; Sakai, S; Shimokata, K | 1 |
Kimura, K; Niitani, H | 1 |
Hara, K; Kado, M; Kanda, T; Matsui, Y; Oshima, S; Shima, K; Shimokata, K; Takenaka, S | 1 |
Hiraga, Y; Ito, T; Konno, K; Nagahama, F; Nakabayashi, T; Nakai, Y; Oizumi, K; Sato, M; Takebe, K; Tamura, M | 1 |
Kooiman, A; Neijt, JP; ten Bokkel Huinink, WW; van der Burg, ME; van Oosterom, AT; van Putten, WL; Vermorken, JB; Vriesendorp, R | 1 |
de Vries, EG; Mulder, NH; Postmus, PE; Sleijfer, DT; Vriesendorp, R; Willemse, PH | 1 |
Suzuki, K | 1 |
Einhorn, LH | 1 |
Maroun, JA; Nundy, D; Prior, J; Stewart, DJ; Tetreault, L | 1 |
Kimura, K; Yamada, K; Yoshida, T | 1 |
Bishop, JF; Campbell, JJ; Day, A; Hillcoat, BL; Pepperell, R; Quinn, MA | 1 |
Beumer, HM | 1 |
6 trial(s) available for podophyllotoxin and Nausea
Article | Year |
---|---|
Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Hig
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Male; Melphalan; Middle Aged; Morpholines; Nausea; Olanzapine; Ondansetron; Podophyllotoxin; Vomiting | 2018 |
[Phase II study of etoposide (NK 171) in advanced hematological malignancies].
Topics: Administration, Oral; Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Leukemia; Leukopenia; Lymphoma; Male; Middle Aged; Nausea; Podophyllotoxin; Prednisolone; Thrombocytosis; Vincristine | 1984 |
[The toxicity of massive dosis of VM26 (4-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside). A contribution to the therapy of advanced ovarian cancer (author's transl)].
Topics: Aged; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Nausea; Ovarian Neoplasms; Podophyllotoxin; Remission, Spontaneous; Teniposide; Vomiting | 1977 |
Bioavailability, pharmacokinetics, and clinical effects of an oral preparation of etoposide.
Topics: Administration, Oral; Biological Availability; Capsules; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Granulocytes; Half-Life; Humans; Infusions, Parenteral; Kinetics; Leukocyte Count; Nausea; Neoplasms; Platelet Count; Podophyllotoxin; Random Allocation | 1985 |
Epipodophyllotoxin VP 16213 in treatment of acute leukaemias, haematosarcomas, and solid tumours.
Topics: Adult; Aged; Agranulocytosis; Alopecia; Antineoplastic Agents; Female; Glycosides; Hodgkin Disease; Humans; Lactones; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Nausea; Neoplasms; Neutrophils; Podophyllotoxin; Remission, Spontaneous; Thrombocytopenia; Vomiting | 1973 |
[Chemotherapy of bronchila cancer. Monotherapy and combination therapy].
Topics: Aged; Antineoplastic Agents; Bronchial Neoplasms; Cyclophosphamide; Cytodiagnosis; Diagnosis, Differential; Diarrhea; Drug Synergism; Humans; Injections, Intravenous; Leukopenia; Male; Middle Aged; Nausea; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Radiography; Tablets; Triaziquone | 1968 |
25 other study(ies) available for podophyllotoxin and Nausea
Article | Year |
---|---|
Fosaprepitant for the prevention of nausea and vomiting in patients receiving BEAM or high-dose melphalan before autologous hematopoietic stem cell transplant.
Topics: Aged; Antiemetics; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cohort Studies; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Morpholines; Nausea; Podophyllotoxin; Prospective Studies; Retrospective Studies; Transplantation Conditioning; Vomiting | 2016 |
VP16-213 in combined modality treatment of small cell carcinoma of the lung.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Methotrexate; Nausea; Neoplasm Staging; Podophyllotoxin | 1982 |
Chemotherapy of refractory germ cell cancer with Etoposide.
Topics: Adolescent; Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Choriocarcinoma; Cisplatin; Dysgerminoma; Etoposide; Humans; Lung Neoplasms; Male; Mesonephroma; Nausea; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin; Retroperitoneal Neoplasms; Testicular Neoplasms | 1983 |
Treatment of small cell lung cancer with VP-16, vincristine, doxorubicin (Adriamycin), cyclophosphamide (EVAC), and high-dose chest radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Leukopenia; Lung Neoplasms; Nausea; Nervous System Diseases; Podophyllotoxin; Vincristine | 1983 |
Oral etoposide in gestational trophoblastic disease.
Topics: Adolescent; Adult; Alopecia; Chorionic Gonadotropin; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Nausea; Parity; Podophyllotoxin; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms | 1984 |
[Effects of oral etoposide in small cell carcinoma of the lung].
Topics: Administration, Oral; Adult; Aged; Capsules; Carcinoma, Small Cell; Etoposide; Humans; Leukopenia; Lung Neoplasms; Male; Nausea; Podophyllotoxin; Thrombocytopenia | 1984 |
High-dose VP-16-213 monotherapy for refractory germinal malignancies: a phase II study.
Topics: Adolescent; Adult; Bone Marrow; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Choriocarcinoma; Combined Modality Therapy; Drug Evaluation; Drug Resistance; Dysgerminoma; Etoposide; Female; Humans; Male; Nausea; Neutropenia; Podophyllotoxin; Pregnancy; Teratoma; Vomiting | 1984 |
Teniposide in refractory ovarian cancer: a phase II study.
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Infusions, Parenteral; Leukopenia; Middle Aged; Nausea; Ovarian Neoplasms; Podophyllotoxin; Teniposide | 1984 |
High-dose VP 16-213 (NSC 141540) for the treatment of patients with previously treated acute leukemia.
Topics: Adult; Antineoplastic Agents; Child; Drug Evaluation; Esophagitis; Etoposide; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Nausea; Pilot Projects; Podophyllotoxin; Vomiting | 1980 |
Phase II evaluation of VP-16-213 (NSC-141540) in patients with advanced ovarian carcinoma resistant to alkylating agents.
Topics: Alkylating Agents; Alopecia; Drug Evaluation; Drug Resistance; Etoposide; Female; Humans; Nausea; Ovarian Neoplasms; Podophyllotoxin; Vomiting | 1978 |
Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trail.
Topics: Adult; Aged; Brain Neoplasms; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Female; Glioma; Hematologic Diseases; Humans; Intracranial Pressure; Lomustine; Male; Middle Aged; Nausea; Neoplasm Metastasis; Nitrosourea Compounds; Podophyllotoxin; Teniposide; Vomiting | 1976 |
Multicenter Phase II trial of etoposide in refractory small cell lung cancer.
Topics: Carcinoma, Small Cell; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Multi-Institutional Systems; Nausea; Podophyllotoxin; Vomiting | 1985 |
[Phase II study of VP-16 (capsule) in solid tumors. A cooperative study].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Capsules; Carcinoma, Hepatocellular; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin; Soft Tissue Neoplasms; Thrombocytopenia | 1985 |
Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dysgerminoma; Etoposide; Female; Fever; Follow-Up Studies; Humans; Male; Nausea; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin; Prognosis; Teratoma | 1985 |
[A phase II study of oral VP-16 in primary lung cancer].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anorexia; Capsules; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin | 1985 |
[A phase II study of NK171 (etoposide)].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Alopecia; Anorexia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin | 1985 |
[A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Anorexia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Injections; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin | 1986 |
[A phase II study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung].
Topics: Adult; Aged; Alopecia; Carcinoma, Small Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin | 1986 |
Teniposide (VM-26) in patients with advanced refractory ovarian cancer: a phase II study of the Netherlands Joint Study Group for Ovarian Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Hematologic Diseases; Humans; Nausea; Ovarian Neoplasms; Podophyllotoxin; Prognosis; Teniposide | 1987 |
High-dose teniposide for refractory malignancies: a phase I study.
Topics: Adult; Aged; Alopecia; Drug Evaluation; Female; Hematologic Diseases; Humans; Male; Middle Aged; Nausea; Neoplasms; Podophyllotoxin; Skin Diseases; Teniposide | 1986 |
[Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group].
Topics: Adult; Aged; Alopecia; Anorexia; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Nausea; Podophyllotoxin; Prostatic Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1986 |
VP 16 plus ifosfamide plus cisplatin as salvage therapy in refractory testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Humans; Ifosfamide; Kidney Diseases; Leukopenia; Male; Nausea; Neoplasm Metastasis; Podophyllotoxin; Testicular Neoplasms; Thrombocytopenia; Vomiting | 1986 |
[Phase II study of NK 171 (etoposide) on malignant lymphomas and acute leukemia. A cooperative study group on NK 171 in hematological malignancies].
Topics: Acute Disease; Adolescent; Adult; Aged; Alopecia; Anorexia; Drug Evaluation; Etoposide; Fatigue; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Nausea; Podophyllotoxin | 1986 |
[Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)].
Topics: Administration, Oral; Alopecia; Anorexia; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Kidney Neoplasms; Male; Nausea; Podophyllotoxin; Prostatic Neoplasms; Testicular Neoplasms; Urogenital Neoplasms | 1985 |
Phase II trial of VP-16-213 in advanced ovarian carcinoma.
Topics: Administration, Oral; Aged; Carcinoma; Cisplatin; Cystadenocarcinoma; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Middle Aged; Nausea; Ovarian Neoplasms; Podophyllotoxin; Vomiting | 1985 |